Dr Vivek Y Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) shares the results of the Point-by-Point Pulsed Field Ablation (+/- Radiofrequency Ablation) to Treat Atrial Fibrillation: A First-in-Human Trial.

The trial looked at tissue selectivity of pulsed field ablation (PFA), which provides safety advantages over radiofrequency ablation (RFA) in treating AFib.

Questions:

1. What is pulsed field ablation (PFA) and what is its potential?

2. What data are you presenting at HRS 2020?

3. What did the data show?

4. What further research should be conducted with this technology?

HRS 2020: Filmed remotely from New York.

Interviewer: Mirjam Boros 

Recording editor: Natascha Wienand